Securian Asset Management Inc. Sells 344 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Securian Asset Management Inc. reduced its position in Henry Schein, Inc. (NASDAQ:HSIC) by 4.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,634 shares of the company’s stock after selling 344 shares during the quarter. Securian Asset Management Inc.’s holdings in Henry Schein were worth $459,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Holocene Advisors LP bought a new stake in shares of Henry Schein in the 3rd quarter valued at about $58,319,000. Healthcare of Ontario Pension Plan Trust Fund purchased a new position in shares of Henry Schein in the 3rd quarter valued at $43,740,000. Southpoint Capital Advisors LP lifted its stake in shares of Henry Schein by 30.0% during the 3rd quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company’s stock worth $189,540,000 after purchasing an additional 600,000 shares during the last quarter. Bank of Montreal Can grew its stake in Henry Schein by 365.6% in the third quarter. Bank of Montreal Can now owns 711,487 shares of the company’s stock valued at $52,095,000 after purchasing an additional 558,689 shares during the last quarter. Finally, Raymond James Financial Inc. bought a new stake in shares of Henry Schein in the 4th quarter valued at about $34,720,000. 96.62% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities research analysts recently commented on the stock. Mizuho started coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 target price for the company. Jefferies Financial Group raised their price target on Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a report on Thursday, January 23rd. Barrington Research reaffirmed an “outperform” rating and issued a $90.00 price target on shares of Henry Schein in a report on Wednesday, February 26th. UBS Group dropped their price objective on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a report on Wednesday, February 26th. Finally, Wells Fargo & Company began coverage on Henry Schein in a research note on Friday, February 14th. They issued an “equal weight” rating and a $80.00 target price for the company. Six analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $81.10.

Henry Schein Stock Up 1.7 %

Shares of HSIC opened at $71.80 on Tuesday. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The firm has a market cap of $8.92 billion, a P/E ratio of 29.55, a PEG ratio of 2.13 and a beta of 0.90. The stock’s 50 day moving average is $74.84 and its two-hundred day moving average is $72.62. Henry Schein, Inc. has a 12 month low of $63.67 and a 12 month high of $82.49.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company had revenue of $3.19 billion for the quarter, compared to analyst estimates of $3.25 billion. During the same quarter in the prior year, the company posted $0.66 earnings per share. The business’s revenue was up 5.8% on a year-over-year basis. Analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.